Epigenetic control of mesenchymal stem cells orchestrates bone regeneration
Open Access
- 6 March 2023
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14, 1126787
Abstract
Recent studies have revealed the vital role of MSCs in bone regeneration. In both self-healing bone regeneration processes and biomaterial-induced healing of bone defects beyond the critical size, MSCs show several functions, including osteogenic differentiation and thus providing seed cells. However, adverse factors such as drug intake and body senescence can significantly affect the functions of MSCs in bone regeneration. Currently, several modalities have been developed to regulate MSCs’ phenotype and promote the bone regeneration process. Epigenetic regulation has received much attention because of its heritable nature. Indeed, epigenetic regulation of MSCs is involved in the pathogenesis of a variety of disorders of bone metabolism. Moreover, studies using epigenetic regulation to treat diseases are also being reported. At the same time, the effects of epigenetic regulation on MSCs are yet to be fully understood. This review focuses on recent advances in the effects of epigenetic regulation on osteogenic differentiation, proliferation, and cellular senescence in MSCs. We intend to illustrate how epigenetic regulation of MSCs orchestrates the process of bone regeneration.Keywords
This publication has 165 references indexed in Scilit:
- Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicineExperimental & Molecular Medicine, 2013
- Role of histone deacetylase inhibitors in the aging of human umbilical cord mesenchymal stem cellsJournal of Cellular Biochemistry, 2013
- Histone Lysine Methylation Dynamics: Establishment, Regulation, and Biological ImpactMolecular Cell, 2012
- Histone Demethylases KDM4B and KDM6B Promotes Osteogenic Differentiation of Human MSCsCell Stem Cell, 2012
- In Osteoporosis, differentiation of mesenchymal stem cells (MSCs) improves bone marrow adipogenesisBiological Research, 2012
- Bone regeneration: current concepts and future directionsBMC Medicine, 2011
- Biophysical Regulation of Histone Acetylation in Mesenchymal Stem CellsBiophysical Journal, 2011
- Histone deacetylase inhibitors decrease proliferation potential and multilineage differentiation capability of human mesenchymal stem cellsCell Proliferation, 2009
- The genomic landscapes of histone H3-Lys9 modifications of gene promoter regions and expression profiles in human bone marrow mesenchymal stem cellsJournal of Genetics and Genomics, 2008
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006